Capturing Readmission Internationally to Prevent Readmission by Safer@Home Group (CURIOS@)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02621723|
Recruitment Status : Unknown
Verified December 2015 by Prabath W.B. Nanayakkara, Amsterdam UMC, location VUmc.
Recruitment status was: Not yet recruiting
First Posted : December 3, 2015
Last Update Posted : December 3, 2015
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
CURIOS@ is a prospective multi-centre cross-sectional study to investigate readmissions in participating units. The data collected is derived from two clinical episodes: the episode containing the re-admission and the previous admission (index admission).
The main aims are:
- Risk factors to predict preventable readmissions in non-surgical patients
- Percentage of subjectively non-preventable and preventable readmissions from patient, carer, their nurses and their physician's point of view
- Comparison for risk factors on readmissions throughout Europe
- Increasing awareness and knowledge for health-care workers on readmissions and its preventability
|Condition or disease|
Data will be derived directly from patients, from the clinical notes of the previous admission and records of discharge communication. Also information from treating physicians, nurses and immediate caregivers will be collected. The data set will contain no directly identifiable variables (data will be registered by using a research code for each patient).
Data collection will include: Hospital-related data, patient-related data, health-related data, time-related data, and physician related data. Also patient feedback is requested.
After obtaining written informed consent, the researcher will ask the patient 7 questions about the (preventability of their) readmission. Also the patient will be asked if one of the direct carers can be approached with 2 questions. The carer will most often be a sibling, a good friend or someone from the neighborhood. We will approach the carer in person or by telephone, and only after explicit permission from the patient. Lastly, we will ask a doctor and nurse (responsible for the patient in the first 24 hours of his readmission) similar questions.
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||1000 participants|
|Target Follow-Up Duration:||6 Months|
|Official Title:||Capturing Readmission Internationally to Prevent Readmission by Safer@Home|
|Study Start Date :||January 2016|
|Estimated Primary Completion Date :||January 2017|
|Estimated Study Completion Date :||January 2018|
- Percentage of readmissions deemed preventable by patients, their informal carers, nurses and physicians [ Time Frame: 1 year ]Of all the readmissions in the study, we will look at the readmissions which are deemed potentially preventable (YES or NO) by all partners of care chain. In the end this will give us a percentage of readmissions judged as potentially preventable by all partners of care chain.
- Causes of preventable readmissions [ Time Frame: 1 year ]
We will ask all partners in the care chain about the causes of the readmissions. These will be categorised:
Disease-related: Natural progress disease, out of control/influence physician or patient - for example: metastasis cancer.
Patient-related: Related to control/influence patient, out of control/influence professionals - for example: a patient who refused extra home care after the index admission.
Human/caregiver-related: Related to the control/influence professionals - for example: poor medication handover after index inclusion.
Organisational: Readmission related to organisational problems - for example: no beds available, transfer from other hospital etc.
Technical: Readmission related to technical defects of materials or equipment - for example: IV-drip home infusion antibiotics broken.
- Risk factors for preventable readmissions [ Time Frame: 1 year ]
For every readmission, we will ask researchers to fill out a dataset with potential risk factors. These are:
- General data regarding readmission: i.e. length of stay, time between index admission and readmission.
- Patient-related factors: i.e. age, sex, marital status, living situation etc.
- Health-related: ie. comorbiditity, frailty score, polypharmacy etc.
- Time-related: i.e. Total admissions in previous year
- Physician related: i.e. was a discharge letter send?
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||18 Years and older (Adult, Older Adult)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
|Sampling Method:||Probability Sample|
- Adult patients aged 18 or above admitted to hospital as unscheduled medical admission for a minimum of a single night following a previous admission within 30 days
- Index admission can be for any procedure (elective/non-elective)
- Index admission at any hospital ward (except psychiatry, pediatrics or gynaecology) for a minimum of a single night during the previous 30 days
- Readmission should be to a medical ward (Medical ward: Cardiology, geriatrics, gastroenterology, hematology, internal medicine, nephrology, neurology, oncology, pulmonary medicine, rheumatology.)
- If a patient is readmitted more than once within the study period, only the first readmission will be included
- The port of entry is through an Emergency Department, Acute Medical Unit or any other clinical ward (i.e. department of internal medicine).
- Patients should all be capable of understanding the study and give written informed consent. They should all be mentally competent.
- Patients readmitted electively for procedures, surgery or chemotherapy
- Patients readmitted for a non-medical specialism (surgery, urology, ent etc..)
- Patients admitted or readmitted who are pregnant
- Patients admitted or readmitted aged under 18
- Patients index or readmission for pediatrics, psychiatry, gynaecology
- Patients who stayed less than one night during index and readmission
- Patients who have been admitted to another institution in their index admission (To facilitate timely case identification and ready access to treating physicians, we will only review same-hospital readmissions)
- A second readmission for the same patient within the study period
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02621723
|Contact: Prabath Nanayakkara, MD, PhD, FRCP||031204444444 ext firstname.lastname@example.org|
|Contact: Louise van Galen, MD||031613767381 ext 6185|
|Hospital of South West Jutland|
|Esbjerg, Denmark, 5270 Odense N|
|Contact: Mikkel Brabrand, MD,PhD email@example.com|
|Principal Investigator: Mikkel Brabrand, MD,PhD|
|VU University Medical Centre|
|Amsterdam, Noord-Holland, Netherlands, 1081 HV|
|Contact: Prabath W Nanayakkara, MD,PhD,FRCP 0031204444444 ext 6179 firstname.lastname@example.org|
|Contact: Louise S van Galen, MD 0031613767381 ext 6185 email@example.com|
|Principal Investigator: Prabath Nanayakkara, MD,PhD,FRCP|
|Academic Medical Centre (AMC)|
|Amsterdam, Netherlands, 1105AZ|
|Contact: Frits Holleman, MD, PhD firstname.lastname@example.org|
|Principal Investigator: Frits Holleman|
|Dordrecht, Netherlands, 3300 AK|
|Contact: Wilma Jansen email@example.com|
|Contact: Ralph So, MD firstname.lastname@example.org|
|Principal Investigator: Ralph So, MD|
|Hoorn, Netherlands, 1624 NP|
|Venlo, Netherlands, 5912 BL|
|Contact: Dennis Barten, MD email@example.com|
|Contact: Loes Hooff, MD firstname.lastname@example.org|
|Principal Investigator: Dennis Barten, MD|
|Sub-Investigator: Loes van Hooff, MD|
|Ysbyty Gwynedd Hospital|
|Bangor, United Kingdom, LL57 2PW|
|Contact: Chris P Subbe, MD,PhD,FRCP email@example.com|
|Principal Investigator: Chris Subbe, MD,PhD,FRCP|
|University Hospital of South Manchester|
|Manchester, United Kingdom, M13 9WL|
|Contact: Tim Cooksley, MD,MRCP firstname.lastname@example.org|
|Principal Investigator: Tim Cooksley, MD,MRCP|
|Responsible Party:||Prabath W.B. Nanayakkara, PhD, MD, FRCP, Amsterdam UMC, location VUmc|
|Other Study ID Numbers:||
|First Posted:||December 3, 2015 Key Record Dates|
|Last Update Posted:||December 3, 2015|
|Last Verified:||December 2015|